Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)
Top Cited Papers
- 26 February 2026
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (1) , 117-129
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Handicapped Research
- Ministero della Salute
- Imperial Experimental Cancer Medicine Centre
- Cancer Treatment and Research Trust
- Department of Health and Social Care
- NIHR Imperial Biomedical Research Centre
- Associazione Italiana per la Ricerca sul Cancro (2022 ID 27841)
- Associazione Italiana per la Ricerca sul Cancro (2023-01)
This publication has 33 references indexed in Scilit:
- mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2024
- Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisJournal of Hepatology, 2024
- Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantationJournal of Hepatology, 2024
- Liver transplantation and resection in patients with hepatocellular cancer and portal vein tumor thrombosis: Feasible and effective?Hepatobiliary & Pancreatic Diseases International, 2023
- Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the “all-comers” protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortiumAmerican Journal of Transplantation, 2023
- Combination immunotherapy for hepatocellular carcinomaJournal of Hepatology, 2023
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinomaJournal of Hepatology, 2022
- Long-term outcomes of deceased donor liver transplantation in hepatocellular carcinoma patients with portal vein tumor thrombus: A multicenter studyEuropean Journal of Surgical Oncology, 2022
- Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinomaLiver Transplantation, 2008
- Banff schema for grading liver allograft rejection: Utility in clinical practiceLiver Transplantation and Surgery, 1999